Dr. Martens
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Dr. Martens generated cash of $167,900,000, which is more than the previous year. Cash used in financing activities reached the amount of -$185,900,000 last year. Net change in cash is therefore -$46,400,000.
Cash Flow
| 2016 | 25.8M | -4.9M | -9.5M |
|---|---|---|---|
| 2018 | 46M | -16.4M | -9.3M |
| 2020 | 116M | -21.9M | -38.6M |
| 2021 | 146.1M | -17.3M | -120.1M |
| 2023 | 71.7M | -52.2M | -92.3M |
| 2024 | 167.9M | -25.5M | -185.9M |
DOCS.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 157.5M | 228M | 117.2M | 58.4M | 67.2M | 37.6M |
Operating activities | ||||||
Net income | 69.2M | 128.9M | 34.7M | 74.8M | -5.7M | -12M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 72.3M | 54.2M | 33.8M | 28.9M | 6.5M | 2.9M |
Stock-based compensation expense | 4M | 500K | 11.5M | 0 | 0 | 0 |
| Deferred income tax benefit | 4M | 500K | 11.5M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 23M | -6.6M | 800K | -16.6M | -4.5M | -400K |
Inventories | -1.6M | -133.19M | -18.1M | -36.1M | 9.2M | 700K |
Accounts payable | -37.7M | -6.1M | 51.2M | 35.7M | 5.4M | 0 |
Cash generated by operating activities | 167.9M | 71.7M | 146.1M | 116M | 46M | 25.8M |
Investing activities | ||||||
Purchases Of Investments | 0 | -1M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -18.2M | -51.4M | -17.3M | -21.9M | -16.4M | -4.3M |
Acquisitions Net | 0 | -1M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -25.5M | -52.2M | -17.3M | -21.9M | -16.4M | -4.9M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 37.8M | 0 | 0 | 0 |
Payments for dividends | -57.8M | -58.4M | 0 | 0 | 0 | 0 |
Repurchases of common stock | -50.5M | 0 | -341.4M | -35M | 0 | 0 |
Repayments of term debt | -43.6M | -29.1M | -134.1M | -3.6M | -4M | -2.7M |
Cash used in financing activities | -185.9M | -92.3M | -120.1M | -38.6M | -9.3M | -9.5M |
Net Change In Cash | -46.4M | -70.5M | -3.6M | 58.8M | 19.2M | 11.4M |
Cash at end of period | 111.1M | 157.5M | 113.6M | 117.2M | 86.4M | 49M |
| Data source | Data source | Data source | Data source | Data source | Data source |